Posted by
U.S. Task Force Updates Breast Cancer Gene Testing Recommendations

U.S. Task Force Updates Breast Cancer Gene Testing Recommendations

By Serena GordonHealthDay Reporter Latest Cancer News TUESDAY, Aug. 20, 2019 (HealthDay News) — Mutations in two genes — BRCA1 and BRCA2 — are known to significantly increase the risk of breast cancer, but experts have long debated which women should be tested for them. New recommendations from the U.S. Preventive Services Task Force (USPSTF) […]

Posted by
Rozlytrek Approved to Treat Tumors With <i>NTRK</i> Gene Fusion

Rozlytrek Approved to Treat Tumors With NTRK Gene Fusion

<img class="healthday_image" src="https://www.medicationjunction.com/wp-content/uploads/2019/08/rozlytrek-approved-to-treat-tumors-with-ntrk-gene-fusion.jpg" alt="News Picture: Rozlytrek Approved to Treat Tumors With NTRK Gene Fusion”> Latest Cancer News MONDAY, Aug. 19, 2019 (HealthDay News) — Rozlytrek (entrectinib), a kinase inhibitor, has received approval to treat adults and adolescents with cancer that carries the genetic defect neurotrophic tyrosine receptor kinase (NTRK) gene fusion and has progressed following […]

Posted by
FDA Approves Inrebic Capsules for Myelofibrosis

FDA Approves Inrebic Capsules for Myelofibrosis

Latest Cancer News FRIDAY, Aug. 16, 2019 (HealthDay News) — Inrebic (fedratinib) capsules have been approved to treat adults with intermediate-2 or high-risk primary or secondary myelofibrosis, making it the second drug approved to treat patients with this disease, the U.S. Food and Drug Administration announced today. Approval of Inrebic for patients with intermediate-2 or […]

Posted by
The power of electromagnetic energy on breast cancer cells

The power of electromagnetic energy on breast cancer cells

Cancer’s ability to spread throughout the body can turn a curable case into an aggressive and sometimes fatal one. A team of engineers and cancer biologists may have found a way to slow down, and even stop, the migration of breast cancer cells. Electromagnetic fields may stop breast cancer cells from dividing and spreading. Cancer, […]

Posted by
Talzenna (talazoparib)

Talzenna (talazoparib)

What is Talzenna? Talzenna is a brand-name prescription medication that’s used to treat certain types of breast cancer in adults. It’s used to treat breast cancer with each of the following characteristics: Hormone receptor-positive or hormone receptor-negative. These cancer cells may or may not have receptors (attachment sites) for estrogen or progesterone. Mutations in BRCA1 […]

Posted by
Xospata (gilteritinib)

Xospata (gilteritinib)

FDA warning: Differentiation syndrome This drug has a boxed warning. This is the most serious warning from the Food and Drug Administration (FDA). A boxed warning alerts doctors and patients about drug effects that may be dangerous. Xospata may cause differentiation syndrome, a dangerous condition in which certain cells change and grow in number. Symptoms […]

Posted by
imatinib (Gleevec)

imatinib (Gleevec)

What is imatinib, and how does it work (mechanism of action)? Imatinib is an oral medication used for treating chronic myeloid leukemia and acute lymphoblastic leukemia. It is classified as a kinase inhibitor. Kinase inhibitors include dasatinib (Sprycel), erlotinib (Tarceva), gefitinib (Iressa), nilotinib (Tasigna), pazopanib (Votrient), sunitinib (Sutent), and vandetanib (Caprelsa). Kinase inhibitors prevent tumors […]

Posted by
America&#8217;s Obesity Epidemic May Mean Some Cancers Are Striking Sooner

America’s Obesity Epidemic May Mean Some Cancers Are Striking Sooner

By Alan MozesHealthDay Reporter Latest Cancer News WEDNESDAY, Aug. 14, 2019 (HealthDay News) — Since the turn of the century, American obesity rates have skyrocketed. And now a new study indicates that as the nation’s waistlines expand, cancers long linked to obesity are striking the middle-aged more than ever before. The finding follows a review […]

Posted by
New Treatments Could Be Powerful Weapons Against Brain Tumors

New Treatments Could Be Powerful Weapons Against Brain Tumors

By Dennis ThompsonHealthDay Reporter Latest Cancer News WEDNESDAY, Aug. 14, 2019 (HealthDay News) — New therapies are showing real promise in fighting the type of brain cancer that claimed the lives of Sens. John McCain and Ted Kennedy, a pair of new clinical trials shows. One experimental treatment injects powerful genes directly into a brain […]

Posted by
Zytiga (abiraterone acetate)

Zytiga (abiraterone acetate)

What is Zytiga? Zytiga is a brand-name prescription medication. It’s used to treat two types of prostate cancer: metastatic castration-resistant prostate cancer (CRPC) metastatic high-risk castration-sensitive prostate cancer (CSPC) Metastatic means the cancer has spread to other parts of the body. Both of these cancers are considered advanced. The word “castration” refers to the lowering […]